Clearline Capital LP - Significant Ownership

Signature - Title
Marc Majzner - Limited Partner
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Clearline Capital LP.

Email me when Clearline Capital LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Clearline Capital LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TXMD TherapeuticsMD, Inc. Common Stock, par value $0.001 per share 5.5% $705K 635K Clearline Capital LP Dec 31, 2024
HRTX HERON THERAPEUTICS, INC. /DE/ Common Stock, par value $0.01 per share 5.3% $11.7M 9.71M Clearline Capital LP Sep 30, 2025
MX MAGNACHIP SEMICONDUCTOR Corp Common Stock, par value $0.01 per share 5.1% $6.18M 1.9M Clearline Capital LP Dec 31, 2024

Schedules 13D/G Reported by Clearline Capital LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.